Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
暂无分享,去创建一个
Sunil Krishnan | Jeffrey E. Lee | Douglas B. Evans | E. Abdalla | J. Vauthey | R. Hwang | Huamin Wang | R. Wolff | P. Pisters | J. Fleming | G. Varadhachary | J. Abbruzzese | S. Krishnan | C. Crane | Charlotte C. Sun | Huamin Wang | Jean-Nicolas Vauthey | Peter W. T. Pisters | Eddie K. Abdalla | Gauri Varadhachary | Matthew H. G. Katz | Jason B. Fleming | Charlotte C. Sun | Rosa F. Hwang | Robert A. Wolff | James L. Abbruzzese | Christopher H. Crane | Jeffrey E. Lee | Douglas B. Evans | M. Katz
[1] Douglas B. Evans,et al. Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer , 2008, Annals of Surgical Oncology.
[2] K. Lillemoe,et al. DNA content and other factors associated with ten‐year survival after resection of pancreatic carcinoma , 1998, Journal of surgical oncology.
[3] J. Yu,et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer , 2006, Journal of Gastrointestinal Surgery.
[4] J. Donohue,et al. Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma: Is Cure Possible? , 2008, Annals of surgery.
[5] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[6] Jeffrey E. Lee,et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head* , 1996 .
[7] Jeffrey E. Lee,et al. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? , 2007, Journal of the American College of Surgeons.
[8] Douglas B. Evans,et al. Adjuvant Therapy for Adenocarcinoma of the Pancreas: Analysis of Reported Trials and Recommendations for Future Progress , 2008, Annals of Surgical Oncology.
[9] C. Ko,et al. Multimodality therapy for pancreatic cancer in the U.S. , 2007, Cancer.
[10] B. Eisenberg,et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas , 2001, Journal of Gastrointestinal Surgery.
[11] Jeffrey E. Lee,et al. Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration , 2001, Annals of Surgical Oncology.
[12] Jeffrey E. Lee,et al. Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma , 2007, Annals of surgery.
[13] Helen Hickey,et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.
[14] Jeffrey E. Lee,et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. , 2008, Journal of the American College of Surgeons.
[15] Jeffrey E. Lee,et al. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy , 2006, Annals of Surgical Oncology.
[16] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[17] D. Winchester,et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.
[18] Jin‐Young Jang,et al. Analysis of Long-term Survivors After Surgical Resection for Pancreatic Cancer , 2006, Pancreas.
[19] P J Kumar,et al. The Exocrine Pancreas. , 1980 .
[20] J. Cusack,et al. Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. , 1994, American journal of surgery.
[21] K. Campbell,et al. Resected periampullary adenocarcinoma: 5-year surVIVOrs and their 6 to 10-year follow-up , 2006 .
[22] Ann Smith,et al. The Pancreas. , 1991, Monographs in pathology.
[23] J. Jeekel,et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. , 1999, Annals of surgery.
[24] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[25] K. Campbell,et al. Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer , 2008, Annals of Surgical Oncology.
[26] F. Ames,et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.
[27] W. Hop,et al. Long-term Survival and Metastatic Pattern of Pancreatic and Periampullary Cancer After Adjuvant Chemoradiation or Observation: Long-term Results of EORTC Trial 40891 , 2007, Annals of surgery.
[28] K. Campbell,et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J. Donohue,et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Douglas B. Evans,et al. The Added Value of Multidisciplinary Care for Patients with Pancreatic Cancer , 2008, Annals of Surgical Oncology.
[31] Peter Neuhaus,et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. , 2007, JAMA.
[32] H. Jeekel. Prognostic factors following curative resection for pancreatic adenocarcinoma. , 2004, Annals of surgery.
[33] T. Colby,et al. Long‐Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving? , 1995, Annals of surgery.
[34] Jeffrey E. Lee,et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] Laura H. Tang,et al. Pancreatic Adenocarcinoma: The Actual 5-Year Survivors , 2008, Journal of Gastrointestinal Surgery.
[36] S. Ellenberg,et al. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. , 1985, Archives of surgery.
[37] S. Gallinger,et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. , 2004, Journal of the American College of Surgeons.
[38] Christopher H. Crane,et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration , 2004, Journal of Gastrointestinal Surgery.
[39] Douglas B. Evans,et al. Tumor‐Node‐Metastasis Staging of Pancreatic Adenocarcinoma , 2008, CA: a cancer journal for clinicians.
[40] Jeffrey E. Lee,et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] Jeffrey E. Lee,et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Jeffrey E. Lee,et al. The Need for Standardized Pathologic Staging of Pancreaticoduodenectomy Specimens , 1996, Pancreas.